Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
21/07/2025 12:30
July 21 (Reuters) - Iteos Therapeutics Inc ITOS.O: ITEOS THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $10.047 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT ITEOS THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $10.047 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT ITEOS THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVES ACQUISITION BY CONCENTRA ITEOS THERAPEUTICS INC - CONCENTRA TO COMMENCE TENDER OFFER BY AUGUST 1, 2025 Source text: ID:nGNX3FrWhC Further company coverage: ITOS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive